Orthofix Medical Reports Preliminary FY23 Net Sales Of $746.3M Versus Consensus Of $741.52M, Up 62% Y/Y On Reported Basis And 61.5% On Constant Currency Basis
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical Inc. reported preliminary FY23 net sales of $746.3M, surpassing the consensus estimate of $741.52M. The company's year-over-year sales increased by 62% on a reported basis and 61.5% on a constant currency basis.
January 09, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Orthofix Medical Inc. exceeded FY23 net sales expectations with a significant year-over-year growth, indicating a strong financial performance.
Orthofix Medical's reported net sales for FY23 not only surpassed the consensus estimates but also showed a substantial year-over-year growth. This positive financial performance is likely to instill confidence in investors and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100